LeukoDx
San Jose, US · Maryland corporation
Find your way into LeukoDx
Sign up to see every warm intro you have to LeukoDx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the LeukoDx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
NN

Nir NimrodiExecutive
Board
BZ
Barry ZubrowBoard director
SH
Steve HurvitzBoard director
MC
Mark ChessBoard director
BS
Bruce SholkBoard director
CP
Charles PiazzaBoard director
MR
Michael ReynierBoard director
Reported raises · per SEC filings
Form D private placements$5M disclosed across 1 round · 2020
▶$5MraisedJul 2020 · 1 investors · BiotechnologyRule 506(b)
▶$5MraisedJul 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bruce SholkDirector
- Barry ZubrowDirector
- Charles PiazzaDirector
- Michael ReynierDirector
- Steve HurvitzDirector
- Mark ChessDirector
- Nir NimrodiDirector
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $5M
- First sale
- Jul 2020
- Incorporated
- Corporation, Maryland
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has LeukoDx raised?
- LeukoDx has disclosed $5M raised across 1 round.
- Where is LeukoDx headquartered?
- LeukoDx is headquartered in San Jose, US.